TMO
THERMO FISHER SCIENTIFIC INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 1 to May 15 ▼ 3 sells: Ro Khanna, Dwight Evans sold, last disclosed Jun 11
- Jul 10 ▼ Dan Newhouse sold $1,001 - $15,000, last disclosed Jul 20
- Jul 23 ▲ Thermo Fisher reported Q2 2026 revenue of $11.99B (+10% YoY) and adj…
- Aug 7 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Sep 7
- Aug 18 Dosch v. Thermo Fisher Scientific Inc. et al
- Aug 21 to Aug 31 ▼ 3 days of insider sells: $9.0M by 2 insiders, avg $623.32
- Sep 3 CLSA initiates
- Sep 30 ▲ 6 funds open new positions (13F)
- Oct 13 ▼ Ro Khanna sold $15,001 - $50,000, last disclosed Nov 9
- Oct 21 ▲ Thermo Fisher Scientific reported Q3 2026 revenue of $12.14B (+9% Yo…
- Oct 21 ▲ Earnings: TMO Q3 2026 Earnings: EPS $6.68 (+3.3% vs est)
- Oct 28 ▼ 1 insider sell $2.0M at $706.45
- Nov 13 New insider trade: subscribers see the details Unlock
Signal stack
Where each data set points today.
- InsidersMIXED
3 insiders sold $11.0M. Excludes 2 subscriber-only trades.
- InstitutionsMIXED
Q3 2026: 63 added (6 new), 44 trimmed or exited. Largest new: Egerton Capital (Uk) $133.8M, Cardano Risk Management B.V $114.6M.
- AnalystsBULLISH
27 of 34 rate it Buy or better. Median target $750.00 (+8%).
- Short sellersSTEADY
Short interest −2.1% to 4.78M shares. 2.0 days to cover, ≈1.3% of shares.
- TrendUPTREND
3% above its 50-day average.
- SocialQUIET
Crowd 58° (warm) this week from 2 mentions: 1 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $15.0B |
| 1832 Asset Management L.P. | TRIM | $820.2M |
| FLOSSBACH VON STORCH SE | TRIM | $614.5M |
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | $522.2M |
| Focus Partners Wealth | TRIM | $403.6M |
| JONES FINANCIAL COMPANIES LLLP | ADD | $400.6M |
| MACKENZIE FINANCIAL CORP | ADD | $332.8M |
| AMERICAN CENTURY COMPANIES INC | DOUBLED | $241.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
34 analystsPrice is inside the target range. Median implies +8%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 30, 2026 | Argus Research MAINTAIN | Buy |
| Oct 23, 2026 | Citigroup MAINTAIN | Buy |
| Oct 22, 2026 | Barclays MAINTAIN | Overweight |
| Oct 22, 2026 | RBC Capital MAINTAIN | Sector Perform |
| Oct 22, 2026 | TD Cowen MAINTAIN | Buy |
| Oct 22, 2026 | Stifel MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
| 🔒 Fresh data, subscribers only Nov 13, 2026 | EXERCISE | |
| 🔒 Fresh data, subscribers only Nov 13, 2026 | SELL | |
| 🔒 Fresh data, subscribers only Nov 13, 2026 | SELL | |
Britt Lisa P. Sr. VP and Chief HR Officer Oct 28, 2026 | SELL | $2.0M |
SPERLING SCOTT M Director Oct 28, 2026 | GIFT | 3,490 sh |
WEISLER DION J Director Sep 26, 2026 | AWARD | 55.56 sh |
Keith R. Alexandra Director Sep 26, 2026 | AWARD | 46.3 sh |
Lynch Karen S Director Sep 26, 2026 | AWARD | 46.3 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
21 filings · 5 bullish · 1 bearish · 15 neutral- NEUTRAL 144Nov 13, 2026
Gianluca Pettiti, an officer of Thermo Fisher Scientific, filed a Form 144 notice of intent to…
The filing is a routine insider intent-to-sell notice. The sale is small relative to the company's market cap and the insider's apparent holdings. No material impact expected. Monitor for any…
- NEUTRAL SC 13GNov 5, 2026
FMR LLC (Fidelity) filed a Schedule 13G disclosing a 6.0% passive stake in Thermo Fisher…
Fidelity's 6.0% passive stake adds a major institutional holder alongside Vanguard and BlackRock. Monitor for any future 13D conversion or changes in stake size, though the passive certification…
- NEUTRAL 8-KOct 30, 2026
Thermo Fisher Scientific announced that Executive Vice President Michael D. Shafer will retire…
Monitor for any subsequent announcement of a replacement for the Executive Vice President role. The retirement is over two months away, suggesting a planned succession process.
- NEUTRAL 144Oct 28, 2026
Lisa Britt, an officer of Thermo Fisher Scientific, filed a Form 144 notice of intent to sell…
This is a routine insider sale of shares acquired through equity compensation. No material impact expected. Monitor for any subsequent Form 4 filings to confirm execution, but no further action…
All TMO filing & press-release reports (21)
- 144 reportNov 13, 2026
- SC 13G reportNov 5, 2026
- 8-K reportOct 30, 2026
- 144 reportOct 28, 2026
- 8-K reportOct 21, 2026
- INST-CLUSTER reportOct 16, 2026
- CLUSTER reportSep 1, 2026
- CLUSTER reportAug 26, 2026
- CLUSTER reportAug 24, 2026
- COURT-RULING reportAug 18, 2026
- CLUSTER reportAug 13, 2026
- CLUSTER reportAug 10, 2026
- CLUSTER reportAug 7, 2026
- 8-K reportJul 23, 2026
- Piper Sandler Initiates TMO at Neutral, PT $510 (+5.8%)Jun 11, 2026
- INST-CLUSTER reportJun 11, 2026
- HSBC downgrades TMO to Hold, PT $540 (-19.4%)Jun 3, 2026
- DEFA14A reportMay 11, 2026
- 8-K reportApr 23, 2026
- DEFA14A reportApr 7, 2026
- INST-CLUSTER reportFeb 28, 2026